Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suk Ran Yoon

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Immunity|February 23, 2005
VDUP1 is required for the development of natural killer cellsKee Nyung Lee, Hyung-Sik Kang, Jun-Ho Jeon, et al.
Journal of Microbiology and Biotechnology|March 18, 2014
Identification of lactoferrin as a human dedifferentiation factor through the studies of reptile tissue regeneration mechanismsKil Soo Bae, Sun Young Kim, Soon Yong Park, et al.
International Journal of Molecular Sciences|December 17, 2020
TXNIP Regulates Natural Killer Cell-Mediated Innate Immunity by Inhibiting IFN-γ Production during Bacterial InfectionDong Oh Kim, Jae-Eun Byun, Won Sam Kim, et al.
Frontiers in Immunology|January 30, 2023
A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targetsHee Young Kang, Soo Yun Lee, Hyun Min Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2010
Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesisHyo-Jung Kwon, Young-Suk Won, Hyun-Woo Suh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2014
Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation studyInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2016
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute LeukemiaInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
Biomaterials|April 13, 2020
A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapyYoung Ha Ahn, Long Ren, Seok Min Kim, et al.
Leukemia|March 18, 2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trialKyoo-Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Immunity|February 23, 2005
VDUP1 is required for the development of natural killer cellsKee Nyung Lee, Hyung-Sik Kang, Jun-Ho Jeon, et al.
Journal of Microbiology and Biotechnology|March 18, 2014
Identification of lactoferrin as a human dedifferentiation factor through the studies of reptile tissue regeneration mechanismsKil Soo Bae, Sun Young Kim, Soon Yong Park, et al.
International Journal of Molecular Sciences|December 17, 2020
TXNIP Regulates Natural Killer Cell-Mediated Innate Immunity by Inhibiting IFN-γ Production during Bacterial InfectionDong Oh Kim, Jae-Eun Byun, Won Sam Kim, et al.
Frontiers in Immunology|January 30, 2023
A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targetsHee Young Kang, Soo Yun Lee, Hyun Min Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2010
Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesisHyo-Jung Kwon, Young-Suk Won, Hyun-Woo Suh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2014
Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation studyInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2016
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute LeukemiaInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
Biomaterials|April 13, 2020
A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapyYoung Ha Ahn, Long Ren, Seok Min Kim, et al.
Leukemia|March 18, 2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trialKyoo-Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, et al.
Pageof 10